Skip to main content
Log in

Granisetron curbs CINV while containing costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Ruiz MA, Garrido J, García Pulgar MS, Alvarez Sanz C.Cost-effectiveness analysis of 5HT3 receptor antagonists for prevention of chemotherapy induced nausea and vomiting. Value in Health 10: A329-A330 (plus poster) abstr. PCN24, No. 6, Nov-Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Granisetron curbs CINV while containing costs. Pharmacoecon. Outcomes News 540, 10 (2007). https://doi.org/10.2165/00151234-200705400-00020

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705400-00020

Keywords

Navigation